VivoSeq
Other

Quality of Life

0

Pipeline Programs

23

Active Trials

18

Companies Involved

Quality of Life is an early-stage landscape with 0 programs across 18 companies. The most active players are Boehringer Ingelheim, Bayer, Johnson & Johnson.

Pipeline Metrics

Competitive Density

38/100

Pipeline Velocity

37/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

5/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

118

clinical trials

Completed71 · 60%
Unknown status17 · 14%
Recruiting11 · 9%
Not yet recruiting7 · 6%
Terminated6 · 5%
Enrolling by invitation3 · 3%
Other3 · 3%

Trial Activity

118 trials

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Recruiting··Phase 2·NCT05765500·110 enrolled
Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
Not yet recruiting··Phase 2·NCT05754801·172 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)